26 July 2013 --- Groupe SOLACTIS SAS, which aims to become a leading French biotech company specializing in nutritional ingredients, for human and animal health, today officially signed the MBO (Management Buy-Out) agreement of the Vitaloa/Solactis Research & Innovation Programme, previously run by SOLVAY SA.
